ASIA News
This collaboration will work with an unnamed pharma company in Japan to know how its drugs behave compared to rival products.
It seeks to develop new care delivery products for acute and chronic disease patients.
The telehealth startup is also looking to offer its platform to insurers and healthcare organisations around the country.
The ANT-X system helps clinicians perform safe and accurate percutaneous needle placement.
The company seeks to further expand in North America, the UK and Singapore.
The startup has developed an AI support tool that detects COVID-19 patterns from chest x-ray images.
The health kiosk automatically dispenses medication to users after a doctor signs off on a prescription in a teleconsultation.
Information obtained through a tool used to quantify a patient's brain tissue volume is used to enhance dementia diagnosis.
The app provides personalised treatment guidance to users based on their BP record, habit logs and behavioural changes.
This comes ahead of the company's reported IPO filing by October.